KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Non-Current Liabilities (2016 - 2025)

Medpace Holdings' Total Non-Current Liabilities history spans 11 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 18.35% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 18.35%, while the annual FY2025 figure was $1.5 billion, 18.35% up from the prior year.
  • Total Non-Current Liabilities reached $1.5 billion in Q4 2025 per MEDP's latest filing, up from $1.4 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.5 billion in Q4 2025 to a low of $576.3 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: soared 68.68% in 2022, then dropped 2.17% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $689.3 million in 2021, then surged by 36.87% to $943.4 million in 2022, then grew by 13.38% to $1.1 billion in 2023, then increased by 15.23% to $1.2 billion in 2024, then increased by 18.35% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Total Non-Current Liabilities are $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.3 billion (Q2 2025).